**Core Concept**
Sentinel lymph node biopsy (SLNB) is a procedure used to identify the first lymph node to which cancer cells are likely to spread from a primary tumor in breast cancer (Ca breast). This concept is based on the idea that the sentinel node is the initial site of metastasis, and its status can predict the overall lymph node involvement.

**Why the Correct Answer is Right**
The sentinel node is identified using a radioactive tracer and/or a blue dye, which is injected into the tumor site. The tracer or dye travels to the sentinel node, allowing surgeons to remove and examine it for cancer cells. The presence or absence of cancer cells in the sentinel node is a strong predictor of the overall lymph node status and guides further treatment decisions, such as whether to perform a full axillary lymph node dissection.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the question, as the sentinel node biopsy is not a treatment for breast cancer.
**Option B:** While lymph node dissection is a treatment for breast cancer, it is not the primary purpose of sentinel node biopsy.
**Option C:** This option is not accurate, as sentinel node biopsy is not used to identify the primary tumor site.

**Clinical Pearl / High-Yield Fact**
The sentinel node biopsy is a valuable tool for reducing the morbidity associated with full axillary lymph node dissection, which can cause lymphedema and other complications. By identifying the sentinel node, surgeons can avoid removing unnecessary lymph nodes and preserve lymphatic function.

**Correct Answer: C. Identifying the sentinel lymph node to assess the spread of cancer cells.**